[1] | Deng, Y., and Scherer, P. E. (2011). Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Sci., 1212, E1–19. |
[2] | Leal, D. V., and Mafra, D. (2013). Adipokines in obesity. Clinica chimica acta, 419, 87–94. |
[3] | Angelova, P., and Boyadjiev, N. (2013). A review on the models of obesity and metabolic syndrome in rats. Trak J Sci, 11(1), 5-12. |
[4] | Ahima, R.S., and Osei, S.Y., (2008): Adipokines in obesity. Front Horm Res., 36, 182 – 197. |
[5] | Hida, K., Wada, J., Eguchi, J., Zhang, H., Baba, M., Seida, A., and Hashimoto, I. (2005). Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. PNAS, 102(30), 10610–15. |
[6] | Li, Q., Chen, R., Moriya, J., Yamakawa, J., Sumino, H., Kanda, T., and Takahashi, T. (2008). A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. The Journal of international medical research, 36(4), 625–9. |
[7] | Kloting, N., Graham, T.E., Berndt, J., Kralisch, S., Kovacs, P., Wason, C.J., Fasshauer, M., Schon, M.R., Stumvoll, M., Bluher, M., and Kahn, B.B. (2007). Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is amarker of intra-abdominal fat mass. Cell Metab. 6, 79–87. |
[8] | Seeger, J., Ziegelmeier, M., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., and Stumvoll, M. (2008). Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clinic Endocrinol metab, 93(1), 247–51. |
[9] | Youn, B.S., Klöting, N., Kratzsch, J., Lee, N., Park, J. W., Song, E.S., and Ruschke, K. (2008). Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes, 57(2), 372–7. |
[10] | Breitfeld, J., Tonjes, A., Gast, M., Schleinitz, D., Bluher, M., Stumvoll, M., and Kovacs, P. (2013). Role of Vaspin in Human Eating Behaviour. PloS one, 8(1), 1–6. |
[11] | Engin-Ustun, Y., Tonguç, E., Var, T., Deveer, R., Yilmaz, N., Danisman, N., and Besli, M. (2013). Vaspin and C-reactive protein levels in hyperemesis gravidarum. European review for medical and pharmacological sciences, 17(1), 138–40. |
[12] | Ko, B., Lee, M., Park, H. S., Han, K., Cho, G. J., Hwang, T. G., and Kim, J. H. (2013). Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children. Endocrine jornal advance puplication. Accepted, doi: 10.1507/endocrj. |
[13] | Messier, C., Whately, K., Liang, J., Du, L., and Puissant, D. (2007). The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behavioural brain research, 178(1), 139–45. |
[14] | El Mesallamy, H. O., El-Demerdash, E., Hammad, L. N., & El Magdoub, H. M. (2010). Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. Diabetology & metabolic syndrome, 2. |
[15] | Couturier, K., Batandier, C., and Awada, M. (2010). Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Archives of Biochemistry and Biophysics. 501(1), 158–61. |
[16] | Nascimento, A., Sugizaki, M., Leopoldo, S., Lima-Leopoldo, A., Nogueir,C., Novelli, E., Padovani C. and Cicogna, A. (2008). Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol. Res., 41, 253-9. |
[17] | Novelli, E., Padovani C. and Cicogna, A. (2008). Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol. Res., 41, 253-9. |
[18] | Parasuraman, S. and Raveendran, R. (2012). Measurement of invasive blood pressure in rats. J Pharmacol Pharmacother, 3(2), 172–77. |
[19] | Parasuraman, S., Raveendran, R., and Kesavan, R. (2010). Blood sample collection in small laboratory animals. J Pharmacol Phamacother. 2, 87–93. |
[20] | Nishizawa, H., Shimomura, I., and Kishida, K. (2002). Androgens decrease plasma adiponectin, an insulin - sensitizing adipocyte-derived protein. Diabetes 51, 2734–41. |
[21] | Tietz, N.W., Cook, T., and McNiven, M.A. (1995): Clinical Guide to Laboratory Tests, W.B. Saunders, Co., Philadelphia, 509-12. |
[22] | Temple, R.C., Clark, P.M., and Hales, C.N. (1992). Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Medicine 9, 503-12. |
[23] | Fossati, P. (1982). Principle Lab. Clin Chem., 28, 2077-79. |
[24] | Nauck, M., Marz, W., and Jarausch, J. (1997). Multicenter evaluation of a homogenous assay for HDL-Cholesterol without sample pretreatment Clin Chem., 43, 1622-29. |
[25] | Friedewald, W. T., Levy, R.I., and Fredrickson, D.S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem., 18, 499-502. |
[26] | Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C. (1985). Homeostasis model assessment: insulin resistance and μ-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-19. |
[27] | Sun, G., Bishop, J., Khalili, S., Vasdev, S., Gill, V., Pace, D., Fitzpatrick, D., Randell, E., Ya- Xie, G. and Zhang, H. (2007). Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr, 85, 399–404. |
[28] | Bergmann, K., and Sypniewska, G. (2013). Diabetes as a complication of adipose tissue dysfunction . Is there a role for potential new biomarkers?. Clin. Chem. Lab. Med., 51(1), 177–85. |
[29] | Blüher, M. (2011). Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine, 41(2), 1–7. |
[30] | Choi, S. H., Kwak, S. H., Lee, Y., Moon, M. K., Lim, S., Park, Y. J., and Jang, H. C. (2011). Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clinic Endocrinol, 75, 628–35. |
[31] | Feng, R., Wang, C., Sun, C., Guo, F., Zhao, C., and Li, Y. (2011). Vaspin in newly and previously diagnosed Chinese type 2 diabetic females: a case-control study. Asian Biomedicine, 5(4), 525–29. |
[32] | Saalbach, A., Vester, K., Rall, K., Tremel, J., Anderegg, U., Beck-Sickinger, A. G., Blüher, M., et al. (2012). Vaspin--a link of obesity and psoriasis? Experimental dermatology, 21(4), 309–12. |
[33] | Youn, B.S., Klöting, N., Kratzsch, J., Lee, N., Park, J. W., Song, E.S., and Ruschke, K. (2008). Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes, 57(2), 372–7. |
[34] | Auguet, T., Quintero, Y., Riesco, D., Morancho, B., Terra, X., Crescenti, A., Broch, M. (2011). New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Medical Genetics, 12(1), 60-68. |
[35] | González, C. R., Caminos, J. E., Vázquez, M. J., Garcés, M. F., Cepeda, L., Ángel, A., and González, C.(2009). Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue. Journal of Physiology, 587(14), 3741–50. |
[36] | Ye, Y., Xu-hong, H., Xiao-ping, P., Jun-xi, L., and Wei-ping, J. (2009). Serum vaspin level in relation to postprandial plasma glucose. chin Med J, 122(08), 2530–3. |
[37] | El-Mesallamy, H. O., Kassem, D. H., El-Demerdash, E., and Amin, A. I. (2011). Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism: clinical and experimental, 60(1), 63–70. |
[38] | Zhang, L., Li, L., Yang, M., Liu, H., and Yang, G. (2011). Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone. Cytokine, 56(2), 399–402. |
[39] | Hida, K., Poulsen, P., Teshigawara, S., Nilsson, E., Friedrichsen, M., Ribel-Madsen, R., and Grunnet, L. (2012). Impact of circulating vaspin levels on metabolic variables in elderly twins. Diabetologia, 55(2), 530–2. |
[40] | Tan, B. K., Heutling, D., Chen, J., Farhatullah, S., Adya, R., Keay, S. D., Kennedy, C. R. (2008). Metformin Decreases the Adipokine Vaspin in Overweight in Insulin Resistance. Diabetes, 57(June), 1501–07. |
[41] | Gulcelik, N. E., Karakaya, J., Gedik, A., Usman, A., and Gurlek, A. (2009). Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol, 160(1), 65–70. |
[42] | Shaker, O. G., and Sadik, A. N. (2013). Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance. Mol Cell Biochem. 373, 229–239. |
[43] | Heiker, J. T., Klöting, N., Kovacs, P., Kuettner, E. B., Sträter, N., Schultz, S., and Kern, M. (2013). Vaspin inhibits kallikrein 7 by serpin mechanism. Cell. Mol. Life Sci. doi:10.1007/s00018-013-1258-8. |
[44] | Krusinová, E., and Pelikánová, T. (2008). Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis? Diab Res Clin Pract, 82 (2), S127–34. |
[45] | Fried, S. K., Bunkin, D. A., and Greenberg, A. S. (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clinic Endocrinol metab, 83(3), 847–50. |
[46] | Loeffelholz, C. Von, Möhlig, M., Isken, F., Spranger, J., Mai, K., Randeva, H. S., and Pfeiffer, A. F. H. (2010). Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol, 162(3), 507–13. |
[47] | Lee, M. K., Jekal, Y., Im, J.A., Kim, E., Lee, S. H., Park, J.H., and Chu, S. H. (2010). Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clinica chimica acta , 411(5-6), 381-85. |
[48] | Inoue, J., Wada, J., Teshigawara, S., Hida, K., Nakatsuka, A., Takatori, Y., and Kojo, S. (2012). The serum vaspin levels are reduced in Japanese chronic hemodialysis patients. BMC nephrology, 13, 163-8. |
[49] | Atya, H. B., Hassan, Z. A., Amin, A. I., and Ali, S. A. E. (2013). Vaspin concentration in obesity , impaired glucose tolerance and Type 2 diabetes in Egypt. Adv.Res.Biol.Sci., 1(2), 6–13. |
[50] | Giomisi, A., Kourtis, A., Toulis, K. a, Anastasilakis, A. D., Makedou, K. G., Mouzaki, M., and Gerou, S. (2011). Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur J Endocrinol, 164(4), 579–83. |
[51] | Korner, A., Neef, M., Friebe, D., Erbs, S., Kratzsch, J., Dittrich, K., and Bluher, S. (2011). Vaspin is related to gender , puberty and deteriorating insulin sensitivity in children. International Journal of Obesity, 35, 578-86. |
[52] | Lee, J. A., Park, H. S., Song, Y. S., Jang, Y. J., Kim, J., Lee, Y. J., and Heo, Y. (2011). Relationship between vaspin gene expression and abdominal fat distribution of Korean women. Endocrine jornal, 58(8), 639–46. |
[53] | Akbarzadeh, S., Nabipour, I., Jafari, S. M., Movahed, A., Motamed, N., Assadi, M., and Hajian, N. (2012). Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diab Res Clin Pract, 95(1), 132-38. |
[54] | Buettner, R., Parhofer, K.G., and Woenckhaus, M. (2006). Defining high fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology, 36(3), 485–501. |
[55] | Jackman, M. R., MacLean, P. S., & Bessesen, D. H. (2010). Energy expenditure in obesity-prone and obesity-resistant rats before and after the introduction of a high-fat diet. Am J Physiol Regul Integr Comp Physiol, 299(4), R1097–105. |
[56] | Panchal, S. K., and Brown, L. (2011). Rodent models for metabolic syndrome research. Journal of biomedicine and biotechnology. 14 pages doi: 10.1155/2011/351982. |
[57] | Bahramikia, S., and Yazdanparast, R. (2009). Efficacy of different fractions of Anethum graveolens leaves on serum lipoproteins and serum and liver oxidative status in experimentally induced hypercholesterolaemic rat models. Am J Chin med, 37(4), 685–99. |
[58] | Biswas, A., Rabbani, S. I., and Devi, K. (2012). Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats. Indian journal of pharmacology, 44(3), 333–39. |
[59] | Basciano, H., Federico, L., and Adeli, K. (2005). Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & metabolism, 2(1), 1-4. |